Myasthenia gravis historical perspective
|
Myasthenia gravis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myasthenia gravis historical perspective On the Web |
|
American Roentgen Ray Society Images of Myasthenia gravis historical perspective |
|
Risk calculators and risk factors for Myasthenia gravis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Discovery
- The first possible patient with Myasthenia gravis, Openchancanough was first described by Virginian Chroniclers in 1664. His symptoms included fatigue, heavy eyelids and weak muscle tone.[1]
- The other case of MG was described by an English doctor Thomas Willis. His patient had weakness and fatigue of muscles and eyelids.[2]
- In the late 1800s the name Myasthenia gravis was created and the classic symptoms of the disease were described.[2][3]
- The autoimmune nature of this disease was first described by Simpson and Nastuck in 1959-1960.[4]
Landmark Events in the Development of Treatment Strategies
- The first important step in treatment of MG occurred in 1934 by Marry Walker. She observed that the symptoms of patients with myasthenia gravis in similar to those with curare poisoning so their symptoms can improve by a cholinesterase inhibitor like physostigmine.[5]
- In 1937 Blalock described an improvement in his patient after removal of the thymus and established thymectomy as one of the treatment options of MG.[2]
- In 1970s the use of immunosuppressants, azathioprine and plasma exchange became more prevalent.[6][7]
Famous Cases
The following are a few famous cases of disease name:
References
- ↑ Marsteller HB (February 1988). "The first American case of myasthenia gravis". Arch. Neurol. 45 (2): 185–7. PMID 3277598.
- ↑ 2.0 2.1 2.2 Pascuzzi RM (May 1994). "The history of myasthenia gravis". Neurol Clin. 12 (2): 231–42. PMID 8041339.
- ↑ Keesey JC (July 2002). ""Crisis" in myasthenia gravis: an historical perspective". Muscle Nerve. 26 (1): 1–3. doi:10.1002/mus.10095. PMID 12115943.
- ↑ NASTUK WL, STRAUSS AJ, OSSERMAN KE (March 1959). "Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis". Am. J. Med. 26 (3): 394–409. PMID 13626994.
- ↑ Walker MB (April 1935). "Case showing the Effect of Prostigmin on Myasthenia Gravis". Proc. R. Soc. Med. 28 (6): 759–61. PMC 2205570. PMID 19990268.
- ↑ Rowland LP (July 1980). "Controversies about the treatment of myasthenia gravis". J. Neurol. Neurosurg. Psychiatry. 43 (7): 644–59. PMC 490631. PMID 7400825.
- ↑ Lehmann HC, Hartung HP, Hetzel GR, Stüve O, Kieseier BC (August 2006). "Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders". Arch. Neurol. 63 (8): 1066–71. doi:10.1001/archneur.63.8.1066. PMID 16908731.